Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering an Exploratory Grant Award (R21) aimed at promoting workforce diversity in basic cancer research. This funding opportunity seeks to support New Investigators and Early Stage Investigators from underrepresented backgrounds in developing innovative cancer research studies, particularly those addressing health disparities among racial and ethnic minorities. The program is part of NIH's ongoing efforts to diversify the biomedical research workforce and enhance research capabilities, with a total award budget not exceeding $275,000 for a maximum period of two years. Interested applicants can find more information and application guidelines at the NIH website, with the application deadline set for November 17, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.